Combined transplantation of skeletal myoblasts and mesenchymal cells (cocultivation) in ventricular dysfunction after myocardial infarction;O transplante em conjunto de células mioblásticas esqueléticas e mesenquimais (cocultivadas) na disfunção ventricular pós-infarto do miocárdio

Arquivos Brasileiros de Cardiologia

Volumn 83, Issue 4, 2004, Pages 288-299

  Guarita Souza, Luiz Cesar ^a,b,c   Teixeira De Carvalho, Katherine Athayde ^a,b   Rebelatto, Carmen ^a,b   Senegaglia, Alessandra ^a,b   Furuta, Marcus ^a,b   Miyague, Nelson ^a,b   Hansen, Paula ^a,b   Francisco, Julio C ^a,b   Slud Brofman, Paulo Roberte ^a,b  

^a Pont Univ Catolica do Parana ^*

^b PONTIFICAL CATHOLIC UNIVERSITY OF PARANÁ   (Brazil)

^c NONE   (Brazil)

Author keywords

Mesenchymal cells; Myocardial infarction; Skeletal myoblasts; Transplantation; Ventricular dysfunction

Indexed keywords

ANGIOGENESIS; ANIMAL EXPERIMENT; ARTICLE; CELL TRANSPLANTATION; COCULTURE; CONTROLLED STUDY; ECHOCARDIOGRAPHY; HEART EJECTION FRACTION; HEART INFARCTION; HEART MUSCLE FIBROSIS; HEART VENTRICLE ENDDIASTOLIC PRESSURE; HEART VENTRICLE FUNCTION; ILIAC CREST; MESENCHYME; MUSCLE BIOPSY; MYOBLAST; NONHUMAN; RAT; REOPERATION;

EID: 8144224755     PISSN: 0066782X     EISSN: None     Source Type: Journal    
DOI: 10.1590/s0066-782x2004001600004     Document Type: Article

References (22)

1. Kajstura J, Leri A, Finato N, et al. Myocite proliferation in end-stage cardiac failure in humans. Proc Natl Acad Sci USA. 1998;95:8801-5.
2. Ghostine S, Carrion C, Guarita Souza LC, et al. Long term efficacy of myoblast transplantation on regional structure and function afer myocardial infartction. Circulation. 2002;106(Suppl I):131-136.
3. Murry C, Wiseman R, Schwartz S, et al. Skeletal myoblast transplantation for repair of myocardial necrosis. J Clin Invest. 1996;98:2512-23.
4. Scorsin M, Hagege A, Vilquin JT, et al. Comparison of the effects of fetal cardiomyocyte and skeletal myoblast transplatation on post-infarct left ventricular function. J Thorac and Cardiovas Surgery. 2000;119:1169-75.
5. Menasché P, Hagége AA, Scorsin M, et al. Myoblast transplantation for heart failure. Lancet. 2001;357:279-80.
6. Strauer BE, Brehm M, Zeus T, et al. Repair of infracted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans. Circulation. 2002;106:1913-8.
7. Arjun D, Shaohua W, Kimberly A, et al. Bone marow-derived cardiomyocites are present in adult human heart. Circulation. 2003;107:1247-9.
8. Orlic D, Kajstura J, Chimenti S, et al. Transplanted adult bone marrow cells repair myocardial infarcts in mice. Ann. N Y Acad Sci. 2001;938:221-9.
9. Menasché P, Hagege A, Vilquin JT, et al. Autologous skeletal myoblast transplantation for severe postinfarction left ventricular dysfunction. J Am. Coll Cardiol. 2003;41:1078-83.
10. Verfaillie CM. Adult stem cells: assessing the case for pluripotency. Trends Cells Bio. 2002;12:502-8.
11. Friedenstein A, Petrakova K, Kurolesova A. Heterotopic of bone marrow. Analysis of percursor cells for osteogenic and hematopoietic tissues. Transplantation. 2002;6:230-247.
12. Bel A, Messas E, Agbulut O, et al. Transplantation of autologous fresh bone marrow into infarcted myocardium: A word of caution. Circulation. 2003;108 [suppl II]:247-252.
13. Delaporte C, Dehaupas M, Fardeau M. Comparison between the growth pattern of cell cultures from normal and Duchenne Dystrophy Muscle. J Neurol Sci. 1984;64:149-60.
14. Boyüm A. Isolation of mononuclear cells and granulocytes from human blood. Scan J Clin Lab Invest. 1968;21(suppl):77-89.
15. Perin E, Dohman H, Radovan B, et al. Transendocardial autologous bone marrow cell transplantation for severe chronic ischemic heart failure. Circulation. 2003;107:2294-302.
16. Malouf NN, Coleman WB, Girsham JW, et al. Adult derived stem cells from the liver become myocytes in the heart in vivo. Am J Pathol. 2001;158:1929-1935.
17. Guarita Souza LC, Carvalho KAT, Rebelato C. The effectivennes of myoblast and bone marrow cells transplantation, on post-infarct ventricular dysfunction. Circulation, 2003;(suppl IV) 108.
18. Pouzet B, Ghostine S, Vilquin JT et al. Is skeletal myoblast transplantation clinically relevant in the era of angiotensin-converting enzyme inhibitors? Circulation. 2001 Sep 18;104(12 Suppl 1):I223-8.
19. Pouzet B, Vilquin JT, Hagege AA, et al. Factors affecting functional outcome after autologous skeletal myoblast transplantation. Ann Thorac Surg. 2001;71:844-50.
20. Pouzet B, Hagege AA, Vilquin JT. Transplantation of autologous skeletal myoblasts in ischemic cardiac insufficiency. J Soc Biol. 2001;195:47-9.
21. Agbulut O, Velde S, Attar N, et al. Which cell type for regeneration of chronically infarcted myocardium? A face-to-face comparison of skeletal myoblasts and marrow-derived hematopoietic stem cells. Circulation. 2003;(suppl IV):108.
22. Zhang Y, Hartzell C, Narlow M, et al. Stem cell-derived cardiomycytes demonstrate arrhythmic potencial. Circulation. 2002;106:1294-9.